What’s New

IfPA Paper Weighs Access to Hepatitis C Cures for Prisoners

Nearly one in five Americans with hepatitis C spends time behind bars each year, making the prison system an opportune environment to test and cure

Read More

ICER Report Could Intensify Barriers for Heart Patients

Accessing innovative cardiovascular drugs may soon get harder. A new publication from the Institute for Clinical and Economic Review, a drug price analysis group, assigns

Read More

***PRESS RELEASE*** STATEMENT FROM ALLIANCE FOR PATIENT ACCESS ON THE SENATE PDUFA REAUTHORIZATION BILL

Physician organization urges the Senate to reauthorize the bill before leaving for August recess WASHINGTON – The Alliance for Patient Access (AfPA) made the following statement

Read More

Experts Envision “Precision” Benefit Design

Health plans often use different levels of cost sharing to drive patients toward one medication over another. But is this practice fair, ethical or effective

Read More

Health Plan Coverage for Biosimilars Raises Questions

Health plans are embracing biosimilars, a new Avalere Health study reveals.  Eighty-one percent of health plans now cover at least one of the two biosimilars

Read More

Cancer Moonshot: One Year Later

It’s been over a year since the launch of former vice president Joe Biden’s Cancer Moonshot, designed to spur innovation and encourage collaboration on finding

Read More

Access Barriers Loom for Movement Disorder Patients

Long-awaited treatment for a movement disorder known as tardive dyskinesia could remain out of reach – unless an upcoming cost-effectiveness analysis acknowledges its value to

Read More

Awareness Month Highlights Migraine’s Impact, Lack of Treatments

Some wore shades, others “showed purple.”  But advocates across the board used June’s Migraine & Headache Awareness Month to draw attention to a condition whose

Read More

Cardiovascular Group Rallies for Better Access Policies

Health plans across the country are rejecting prescriptions for cholesterol-lowering PCSK9 inhibitors at an average rate of 43 percent. And now one patient advocacy group

Read More

Massachusetts Pursues Better Access, Less Failure for Epilepsy Patients

In Massachusetts, some patients with epilepsy must try and fail on their health plans’ preferred prescription medications not once, not twice, but three times before

Read More
Back to Top